ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO981

Clinicopathological Features and Prognostic Outcomes of Adenovirus Nephritis: A Systematic Review of 51 Cases

Session Information

Category: Pathology and Lab Medicine

  • 1800 Pathology and Lab Medicine

Authors

  • Doan, Khanh Duy, Temple University, Philadelphia, Pennsylvania, United States
  • Cassol, Clarissa Araujo, Arkana Laboratories, Little Rock, Arkansas, United States
Background

Adenovirus nephritis is a rare condition primarily associated with kidney allografts, presenting significant diagnostic and management challenges.

Methods

A systematic review was conducted on published data concerning adenovirus nephritis.

Results

36 studies comprising 51 cases (47 allograft kidneys, 4 native kidneys) were included. Median age is 45 years and males are predominant. 72.3% occurred within the first year post-transplantation. Presentations included fever (72.5%), gross hematuria (52.9%), dysuria (39.2%), and graft pain (17.6%). Kidney biopsy patterns was shown in table 1. Adenovirus immunohistochemistry demonstrated high sensitivity (94.1%), while electron microscopy identified viral particles in 45% of cases. Immunosuppressive treatment reduction occurred in most patients (95.7%), with only 36.2% receiving antiviral therapy. Allograft failure was rare (4.4%), despite aggressive presentation, with 84.4% of patients experiencing creatinine normalization post-treatment.

Conclusion

Adenovirus immunohistochemistry showed high sensitivity, albeit limited availability. Despite its aggressive presentation, adenovirus nephritis infrequently results in graft failure.

Kidney biopsy results
 Cases (51)Percentage (%)
Tubulointerstitial inflammation4792.2
Granuloma3058.8
Viro-pathic changes2854.9
Interstitial necrotizing 2243.1
Interstitial hemorrhage1325.5

Figure 1. Study flowchart

Figure 2. Global distribution of cases